Print Save or Share

User Reviews for Omnitrope

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Omnitrope.

Condition	Reviews	Compare	Avg. Ratings
Pediatric Growth Hormone Deficiency	0 reviews	14 medications		10
Adult Human Growth Hormone Deficiency	0 reviews	11 medications	Not rated - Be the first
Short Stature for Age	0 reviews	15 medications	Not rated - Be the first

Reviews for Omnitrope

There are no reviews - Be the first

See also...

Sign In or Register

Forgot password?

Related Omnitrope Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Growth hormones

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

Get Updates by Email

Email me about Omnitrope:

Related News and Articles

Prolor Biotech Announces Positive Top-Line Results From Pilot Study of Its Long-Acting Human Growth Hormone Injected Twice Per Month 18 January 2012
-Post-Phase II hGH-CTP Study Shows Promise for Regimen in Which 2 hGH-CTP Injections Per Month Could Replace Current Regimen of 30 Growth Hormone Injections...
PROLOR Biotech Announces Positive Top-Line Results From Pilot Study of Its Long-Acting Human Growth Hormone Injected Twice Per Month 18 January 2012
Post-Phase II hGH-CTP Study Shows Promise for Regimen in Which 2 hGH-CTP Injections Per Month Could Replace Current Regimen of 30 Growth Hormone Injections...
FDA Drug Safety Communication: Safety review update of Recombinant Human Growth Hormone (somatropin) and possible increased risk of death 5 August 2011
This safety review update is in follow-up to the FDA Drug Safety Communication: Ongoing safety review of Recombinant Human Growth Hormone (somatropin) and...
PROLOR Biotech Announces Positive Top-Line Results From Phase II Trial of its Long-Acting Human Growth Hormone That Achieved All Key Study Goals 4 August 2011
Trial of hGH-CTP in Growth Hormone Deficient Adults Achieved Key Efficacy and Safety Endpoints-- --Positive Results Set Stage for Initiating Phase III...
Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death 4 August 2011
FDA has determined that, at this time, the evidence regarding recombinant human growth hormone and increased risk of death is inconclusive. In its analysis...

Related Questions & Answers

More Omnitrope questions

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

Copyright © 2000-2012 Drugs.com. All rights reserved.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

(web4)